Entities / Company
Novartis.
Czech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 10
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Novartis' drug failure has negatively impacted Amgen's financial outlook.Some support2 reports1 development inside
-
Dannielle Appelhans began her career at McKinsey & Company, gained experience, held senior roles, and led a strategic collaboration involving Eli Lilly and Company, Novartis, and Hoffmann-La Roche.Some support1 report
-
Novartis is advancing a biologic using its platform, with Phase 1b data presentations scheduled at the ERS Congress.Some support1 report
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Novartis this week
News at the entities that move Novartis most-
Amgen OperationalMSKCC director Rudin presented trial data involving Amgen on October 25, 2026.Moves Novartis
Connections
The 2 strongest of 10, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 events- Dannielle Appelhans began her career at McKinsey & Company, gained experience, held senior roles, and led a strategic collaboration involving Eli Lilly and Company, Novartis, and Hoffmann-La Roche.
- Novartis is advancing a biologic using its platform, with Phase 1b data presentations scheduled at the ERS Congress.